Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients

SIMPLE SUMMARY: Adjuvant treatment of stage III/IV melanoma patients with immune-checkpoint inhibition or targeted therapy can significantly improve recurrence-free survival. However, it is unknown how many patients with an indication for adjuvant therapy do indeed choose to receive it and what the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Autores principales: Lodde, Georg, Forschner, Andrea, Hassel, Jessica, Wulfken, Lena M., Meier, Friedegund, Mohr, Peter, Kähler, Katharina, Schilling, Bastian, Loquai, Carmen, Berking, Carola, Hüning, Svea, Schatton, Kerstin, Gebhardt, Christoffer, Eckardt, Julia, Gutzmer, Ralf, Reinhardt, Lydia, Glutsch, Valerie, Nikfarjam, Ulrike, Erdmann, Michael, Stang, Andreas, Kowall, Bernd, Roesch, Alexander, Ugurel, Selma, Zimmer, Lisa, Schadendorf, Dirk, Livingstone, Elisabeth
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8151445/
https://ncbi.nlm.nih.gov/pubmed/34065995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13102319
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares